Elysium Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 22.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 16.00 Cr
as on 05-07-2024
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 302.72 Cr
as on 05-07-2024
- Satisfied Charges ₹ 41.65 Cr
as on 05-07-2024
- Revenue 93.92%
(FY 2021)
- Profit 208.42%
(FY 2021)
- Ebitda 90.74%
(FY 2021)
- Net Worth 49.63%
(FY 2021)
- Total Assets 28.39%
(FY 2021)
About Elysium Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 22.00 Cr and a paid-up capital of Rs 16.00 Cr.
The company currently has active open charges totaling ₹302.72 Cr. The company has closed loans amounting to ₹41.65 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Elysium Pharmaceuticals Ltd India are Poonam Lashwani as COMPANY SECRETARY and Chairag Desai as Cfo. Shitalkumar Patel, Vithalbhai Patel, Suhasini Patel, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24231GJ1995PLC024164
- Company No.
024164
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Jan 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Elysium Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yashwantrai Patel  | Managing Director | 25-Sep-2015 | Current |
| Poonam Lashwani | Company Secretary | 12-Mar-2024 | Current |
| Chairag Desai | CFO | 02-Apr-2019 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shitalkumar Patel | Whole-Time Director | 30-Jan-2020 | Current |
| Vithalbhai Patel | Director | 21-Jun-2006 | Current |
| Suhasini Patel | Whole-Time Director | 11-Jan-1995 | Current |
| Chandani Jhanwar | Director | 17-Feb-2023 | Current |
| Jinkal Patel | Whole-Time Director | 30-Jan-2020 | Current |
Financial Performance and Corporate Structure Insights of Elysium Pharmaceuticals.
Elysium Pharmaceuticals Ltd, for the financial year ended 2021, experienced significant growth in revenue, with a 93.92% increase. The company also saw a substantial improvement in profitability, with a 208.42% increase in profit. The company's net worth Soared by an impressive increase of 49.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elysium Pharmaceuticals?
In 2021, Elysium Pharmaceuticals had a promoter holding of 92.13% and a public holding of 7.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Mar 2022 | ₹2.29 Cr | Open |
Others Creation Date: 11 Mar 2022 | ₹31.44 Cr | Open |
Others Creation Date: 27 Oct 2021 | ₹26.00 Cr | Open |
How Many Employees Work at Elysium Pharmaceuticals?
Elysium Pharmaceuticals has a workforce of 352 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elysium Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elysium Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
